Biotech Analyst Yee, along with Dr. Giles Yeo, University of Cambridge Institute of Metabolic Science, discuss understanding GLP/GIPR in Obesity and reviewing Amgen’s AMG-133 data on an Analyst/Industry conference call to be held on February 26 at 10 am. Webcast Link
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on AMGN:
- Amgen to host conference call
- Amgen call volume above normal and directionally bullish
- Amgen downgraded, Enphase upgraded: Wall Street’s top analyst calls
- Amgen price target raised to $329 from $303 at RBC Capital
- Amgen price target raised to $380 from $350 at Oppenheimer
Questions or Comments about the article? Write to editor@tipranks.com